Watson Pharmaceuticals Inc. (ACT)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
18-Sep-13 6:17 PM
View: 
Hummel Albert F
Director
Watson Pharmaceuticals Inc. (ACT) 16-Sep-17Gift 3,800----(4%)
92.78K to 88.98K
02-Oct-13 9:25 PM
View: 
Turner Andrew L
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 5,441----(100%)
5.44K to 0
02-Oct-13 8:53 PM
View: 
Eagan Patrick
Chief HR Officer - Global
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 14,209----(100%)
14.21K to 0
02-Oct-13 9:11 PM
View: 
Mayr Charles M
Chief Communic Off-Global
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 21,396----(100%)
21.4K to 0
02-Oct-13 9:23 PM
View: 
Michelson Jack
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 1,877----(100%)
1.88K to 0
02-Oct-13 9:13 PM
View: 
Olafsson Sigurdur O
Pres.-Global Generics
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 96,947----(100%)
96.95K to 0
02-Oct-13 9:16 PM
View: 
Stewart Robert A
Pres-Global Operations
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 71,252----(100%)
71.25K to 0
02-Oct-13 9:21 PM
View: 
Klema Cathy
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 19,608----(100%)
19.61K to 0
02-Oct-13 9:19 PM
View: 
Fedida Michael J
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 25,382----(100%)
25.38K to 0
02-Oct-13 9:14 PM
View: 
Paonessa Albert III
President of Anda, Inc.
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 33,729----(100%)
33.73K to 0
02-Oct-13 9:20 PM
View: 
Feldman Michel J
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 500----(100%)
0.5K to 0
02-Oct-13 9:03 PM
View: 
Fridriksdottir Hafrun
Sr VP, Global Generics R&D
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 5,645----(100%)
5.64K to 0
02-Oct-13 9:10 PM
View: 
Joyce R Todd
CFO-Global
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 73,812----(96%)
77.09K to 3.28K
02-Oct-13 8:44 PM
View: 
Bisaro Paul
President & CEO
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 440,916----(100%)
440.92K to 0
02-Oct-13 8:59 PM
View: 
Ebert Charles D
Sr. VP, Research & Development
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 18,488----(100%)
18.49K to 0
02-Oct-13 9:18 PM
View: 
Bodine Chris W
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 14,629----(100%)
14.63K to 0
02-Oct-13 9:20 PM
View: 
Hummel Albert F
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 82,776----(100%)
82.78K to 0
02-Oct-13 9:23 PM
View: 
Taylor Ronald R
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 27,942----(100%)
27.94K to 0
02-Oct-13 9:26 PM
View: 
Weiss Fred G
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 27,275----(100%)
27.27K to 0
02-Oct-13 9:10 PM
View: 
Joyce R Todd
CFO-Global
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 3,283----(100%)
3.28K to 0
02-Oct-13 8:49 PM
View: 
Buchen David A
Chief Legal Officer-Global&Sec
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 89,966----(100%)
89.97K to 0
02-Oct-13 9:17 PM
View: 
Wilkinson George Fred
Pres-Global Brands&Biosimilars
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 45,412----(100%)
45.41K to 0
02-Oct-13 9:20 PM
View: 
Feldman Michel J
Director
Watson Pharmaceuticals Inc. (ACT) 01-Oct-13Disposition 12,941----(96%)
13.44K to 0.5K
02-Oct-13 9:03 PM
View: 
Fridriksdottir Hafrun
Sr VP, Global Generics R&D
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 4,318----250%
1.73K to 6.04K
02-Oct-13 9:03 PM
View: 
Fridriksdottir Hafrun
Sr VP, Global Generics R&D
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Option Exercise 5,110----85%
6.04K to 11.15K
02-Oct-13 9:10 PM
View: 
Joyce R Todd
CFO-Global
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 38,443----46%
83.75K to 122.2K
02-Oct-13 8:44 PM
View: 
Bisaro Paul
President & CEO
Director
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 140,760----30%
462.23K to 602.99K
02-Oct-13 9:11 PM
View: 
Mayr Charles M
Chief Communic Off-Global
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 21,462$144.00$3,090,530.00(50%)
42.86K to 21.4K
83%
02-Oct-13 9:10 PM
View: 
Joyce R Todd
CFO-Global
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 45,101$144.00$6,494,540.00(37%)
122.2K to 77.09K
83%
02-Oct-13 8:59 PM
View: 
Ebert Charles D
Sr. VP, Research & Development
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 12,212----61%
19.97K to 32.18K
02-Oct-13 9:16 PM
View: 
Stewart Robert A
Pres-Global Operations
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 121,951$144.00$17,560,900.00(63%)
193.2K to 71.25K
83%
02-Oct-13 8:59 PM
View: 
Ebert Charles D
Sr. VP, Research & Development
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 13,694$144.00$1,971,940.00(43%)
32.18K to 18.49K
83%
02-Oct-13 9:14 PM
View: 
Paonessa Albert III
President of Anda, Inc.
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 16,843$144.00$2,425,390.00(33%)
50.57K to 33.73K
83%
02-Oct-13 8:53 PM
View: 
Eagan Patrick
Chief HR Officer - Global
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 15,291$144.00$2,201,900.00(52%)
29.5K to 14.21K
83%
02-Oct-13 8:49 PM
View: 
Buchen David A
Chief Legal Officer-Global&Sec
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 38,441----39%
97.37K to 135.81K
02-Oct-13 9:13 PM
View: 
Olafsson Sigurdur O
Pres.-Global Generics
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 181,845$144.00$26,185,700.00(65%)
278.79K to 96.95K
83%
02-Oct-13 8:49 PM
View: 
Buchen David A
Chief Legal Officer-Global&Sec
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 45,848$144.00$6,602,110.00(34%)
135.81K to 89.97K
83%
02-Oct-13 9:16 PM
View: 
Stewart Robert A
Pres-Global Operations
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Option Exercise 75,000$86.86$6,514,500.0063%
118.2K to 193.2K
02-Oct-13 9:17 PM
View: 
Wilkinson George Fred
Pres-Global Brands&Biosimilars
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 39,612----80%
49.23K to 88.84K
02-Oct-13 9:03 PM
View: 
Fridriksdottir Hafrun
Sr VP, Global Generics R&D
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 5,510$144.00$793,440.00(49%)
11.15K to 5.64K
83%
02-Oct-13 8:53 PM
View: 
Eagan Patrick
Chief HR Officer - Global
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 11,952----81%
14.7K to 26.65K
02-Oct-13 9:11 PM
View: 
Mayr Charles M
Chief Communic Off-Global
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 20,379----91%
22.48K to 42.86K
02-Oct-13 8:53 PM
View: 
Eagan Patrick
Chief HR Officer - Global
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Option Exercise 2,851----11%
26.65K to 29.5K
02-Oct-13 9:13 PM
View: 
Olafsson Sigurdur O
Pres.-Global Generics
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 44,149----52%
84.64K to 128.79K
02-Oct-13 9:16 PM
View: 
Stewart Robert A
Pres-Global Operations
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 44,312----60%
73.89K to 118.2K
02-Oct-13 9:13 PM
View: 
Olafsson Sigurdur O
Pres.-Global Generics
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Option Exercise 150,000$86.86$13,029,000.00116%
128.79K to 278.79K
02-Oct-13 8:44 PM
View: 
Bisaro Paul
President & CEO
Director
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 162,076$144.00$23,338,900.00(27%)
602.99K to 440.92K
83%
02-Oct-13 9:14 PM
View: 
Paonessa Albert III
President of Anda, Inc.
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Grant 16,760----50%
33.81K to 50.57K
02-Oct-13 9:17 PM
View: 
Wilkinson George Fred
Pres-Global Brands&Biosimilars
Watson Pharmaceuticals Inc. (ACT) 30-Sep-13Payment of Exercise 43,429$144.00$6,253,780.00(49%)
88.84K to 45.41K
83%
24-Sep-13 6:01 PM
View: 
Wilkinson George Fred
Pres-Global Brands&Biosimilars
Watson Pharmaceuticals Inc. (ACT) 21-Sep-13Payment of Exercise 3,240$135.50$439,020.00(6%)
52.47K to 49.23K
82%